Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Jin Medical International Ltd. ( (ZJYL) ).
On May 2, 2025, Jin Medical International Ltd. received a deficiency letter from Nasdaq, indicating non-compliance with the minimum bid price requirement of $1.00 per share for its ordinary shares. The company has until October 29, 2025, to regain compliance, with options including a reverse stock split. Failure to comply could lead to delisting, but Jin Medical is actively monitoring its stock price and exploring options to meet the requirement.
More about Jin Medical International Ltd.
Founded in 2006 and headquartered in Changzhou, Jiangsu Province, China, Jin Medical International Ltd. designs, develops, manufactures, and markets wheelchairs and living aids for people with disabilities, the elderly, and rehabilitation purposes. The company operates two manufacturing plants in Changzhou City and Taizhou City, with a new facility under construction in Chuzhou, Anhui Province. Jin Medical has over 40 distributors in China and more than 20 international distributors, with a significant portion of its products sold to Japan and China.
Average Trading Volume: 292,902
Technical Sentiment Signal: Sell
Current Market Cap: $119.3M
See more data about ZJYL stock on TipRanks’ Stock Analysis page.